ENTRY       K12959                      KO
NAME        CAV3
DEFINITION  caveolin 3
PATHWAY     ko04144  Endocytosis
            ko04510  Focal adhesion
            ko05100  Bacterial invasion of epithelial cells
            ko05205  Proteoglycans in cancer
DISEASE     H00567  Caveolinopathies
            H00593  Limb-girdle muscular dystrophy (LGMD)
            H00720  Long QT syndrome
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Cellular Processes
              Transport and catabolism
               04144 Endocytosis
                K12959  CAV3; caveolin 3
              Cell communication
               04510 Focal adhesion
                K12959  CAV3; caveolin 3
             Human Diseases
              Cancers
               05205 Proteoglycans in cancer
                K12959  CAV3; caveolin 3
              Infectious diseases
               05100 Bacterial invasion of epithelial cells
                K12959  CAV3; caveolin 3
GENES       HSA: 859(CAV3)
            PTR: 738786(CAV3)
            PPS: 100987875(CAV3)
            GGO: 101128051(CAV3)
            PON: 100440174(CAV3)
            MCC: 702163(CAV3)
            MCF: 102133753(CAV3)
            MMU: 12391(Cav3)
            RNO: 29161(Cav3)
            CGE: 100773488(Cav3)
            HGL: 101716522(Cav3)
            TUP: 102481829(CAV3)
            CFA: 484671(CAV3)
            AML: 100473119
            FCA: 101081453(CAV3)
            PTG: 102952406(CAV3)
            BTA: 615310(CAV3)
            BOM: 102272328(CAV3)
            PHD: 102316027(CAV3)
            CHX: 102189719(CAV3)
            SSC: 641358(CAV3)
            CFR: 102509085(CAV3)
            BACU: 103014158(CAV3)
            LVE: 103082615(CAV3)
            ECB: 100058881(CAV3)
            MYB: 102239844(CAV3)
            MYD: 102754131(CAV3)
            PALE: 102879431(CAV3)
            MDO: 100023521(CAV3)
            SHR: 100922621(CAV3)
            GGA: 378796(CAV3)
            MGP: 100543378
            TGU: 100230016(CAV3)
            FAB: 101818067(CAV3)
            PHI: 102107046(CAV3)
            APLA: 101792227(CAV3)
            FPG: 101917303(CAV3)
            FCH: 102051891(CAV3)
            CLV: 102098428(CAV3)
            ASN: 102375612(CAV3)
            AMJ: 102560790(CAV3)
            PSS: 102443696(CAV3)
            CMY: 102937725(CAV3)
            ACS: 100552705
            PBI: 103065936
            XLA: 379866(cav3.2)
            XTR: 100124941(cav3.2) 100125124(cav3.1)
            DRE: 449679(cav3)
            TRU: 101073024
            MZE: 101484108
            OLA: 101171655
            XMA: 102227510
            LCM: 102354564 102362893(CAV3)
            CMK: 103176735(cav3)
            BFO: BRAFLDRAFT_116694
            SPU: 100892256
            NVI: 100113488
            BMOR: 101746801
            ISC: IscW_ISCW022515
            TAD: TRIADDRAFT_56887
REFERENCE   PMID:16203612
  AUTHORS   Pietiainen VM, Marjomaki V, Heino J, Hyypia T
  TITLE     Viral entry, lipid rafts and caveosomes.
  JOURNAL   Ann Med 37:394-403 (2005)
REFERENCE   PMID:18448666
  AUTHORS   Karjalainen M, Kakkonen E, Upla P, Paloranta H, Kankaanpaa P, Liberali P, Renkema GH, Hyypia T, Heino J, Marjomaki V
  TITLE     A Raft-derived, Pak1-regulated entry participates in alpha2beta1 integrin-dependent sorting to caveosomes.
  JOURNAL   Mol Biol Cell 19:2857-69 (2008)
REFERENCE   PMID:19380584
  AUTHORS   Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, Nishi M, Takeshima H, Ma J
  TITLE     Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.
  JOURNAL   J Biol Chem 284:15894-902 (2009)
///
